Pancreatic Enzyme Use Reduces Pancreatitis Frequency in Children With Acute Recurrent or Chronic Pancreatitis: A Report From INSPPIRE

Author:

Freeman Alvin Jay1ORCID,Ng Kenneth2ORCID,Wang Fuchenchu3ORCID,Abu-El-Haija Maisam A.4,Chugh Ankur5ORCID,Cress Gretchen A.6ORCID,Fishman Douglas S.7,Gariepy Cheryl E.1ORCID,Giefer Matthew J.8ORCID,Goday Praveen1,Gonska Tanja Y.9,Grover Amit S.10ORCID,Lindblad Douglas11ORCID,Liu Quin Y.12ORCID,Maqbool Asim13ORCID,Mark Jacob A.14ORCID,McFerron Brian A.15,Mehta Megha S.16ORCID,Morinville Veronique D.17,Noel Robert A.18ORCID,Ooi Chee Y.19ORCID,Perito Emily R.20,Schwarzenberg Sarah Jane21ORCID,Sellers Zachary M.22ORCID,Wilschanski Michael23,Zheng Yuhua24ORCID,Yuan Ying3ORCID,Andersen Dana K.25ORCID,Lowe Mark E.26ORCID,Uc Aliye6ORCID,

Affiliation:

1. Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio, USA;

2. Johns Hopkins Children's Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;

3. The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA;

4. Cincinnati Children's Hospital Medical Center, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA;

5. Children's Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA;

6. University of Iowa, Stead Family Children's Hospital, Iowa City, Iowa, USA;

7. Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA;

8. Ochsner Hospital for Children, New Orleans, Louisiana, USA;

9. Hospital for Sick Children, Toronto, Ontario, Canada;

10. Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA;

11. Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA;

12. Cedars-Sinai Medical Center, Los Angeles, California, USA;

13. Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA;

14. University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA;

15. Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA;

16. University of Texas Southwestern Medical School, Dallas, Texas, USA;

17. Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada;

18. Baylor College of Medicine, San Antonio, Texas, USA;

19. University of New South Wales, Sydney Children's Hospital Randwick, Sydney, Australia;

20. University of California San Francisco, San Francisco, California, USA;

21. University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, USA;

22. Stanford University, Palo Alto, California, USA;

23. Hadassah Hebrew University Hospital, Jerusalem, Israel;

24. Children's Hospital Los Angeles, Los Angeles, California, USA;

25. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland, USA;

26. Washington University School of Medicine, St. Louis, Missouri, USA.

Abstract

INTRODUCTION: Among children who suffer from acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP), acute pancreatitis (AP) episodes are painful, often require hospitalization, and contribute to disease complications and progression. Despite this recognition, there are currently no interventions to prevent AP episodes. In this retrospective cohort study, we assessed the impact of pancreatic enzyme therapy (PERT) use on clinical outcomes among children with pancreatic-sufficient ARP or CP. METHODS: Children with pancreatic-sufficient ARP or CP in the INSPPIRE-2 cohort were included. Clinical outcomes were compared for those receiving vs not receiving PERT, as well as frequency of AP before and after PERT. Logistic regression was used to study the association between development of AP episodes after starting PERT and response predictors. RESULTS: Among 356 pancreatic-sufficient participants, 270 (76%) had ARP, and 60 (17%) received PERT. Among those on PERT, 42% did not have a subsequent AP episode, during a mean 2.1 years of follow-up. Children with a SPINK1 mutation (P = 0.005) and those with ARP (compared with CP, P = 0.008) were less likely to have an AP episode after starting PERT. After initiation of PERT, the mean AP annual incidence rate decreased from 3.14 down to 0.71 (P < 0.001). DISCUSSION: In a retrospective analysis, use of PERT was associated with a reduction in the incidence rate of AP among children with pancreatic-sufficient ARP or CP. These results support the need for a clinical trial to evaluate the efficacy of PERT to improve clinical outcomes among children with ARP or CP.

Funder

Division of Diabetes, Endocrinology, and Metabolic Diseases

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3